The modulation of Amyotrophic Lateral Sclerosis risk by Ataxin-2 intermediate polyglutamine expansions is a specific effect-Reference-Cited by-同舟云学术

The modulation of Amyotrophic Lateral Sclerosis risk by Ataxin-2 intermediate polyglutamine expansions is a specific effect

Published:2012-01 Issue:1 Volume:45 Page:356-361
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Gispert Suzana,Kurz Alexander,Waibel Stefan,Bauer Peter,Liepelt Inga,Geisen Christof,Gitler Aaron D.,Becker Tim,Weber Markus,Berg Daniela,Andersen Peter M.,Krüger Rejko,Riess Olaf,Ludolph Albert C.,Auburger Georg

Funder

DFG

NIH Director's New Innovator Award

NIH

The Pew Charitable Trusts

Publisher

Elsevier BV

Subject

Neurology

Reference80 articles.

1. Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease;Abahuni;Neurosci. Lett.,2007

2. dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1;Al-Ramahi;PLoS Genet.,2007

3. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group;Andersen;Amyotroph. Lateral Scler.,2007

4. Spinocerebellar Ataxia type 2, Chapter 26;Auburger,2011

5. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients;Berg;Mov. Disord.,2005

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ataxin‐2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling;The FEBS Journal;2024-02-03

2. Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population;Biomedicines;2024-02-02

3. Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins;Nature Communications;2023-10-14

4. Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins;2023-04-07

5. Modeling amyotrophic lateral sclerosis through Ataxin-2 pathology;Handbook of Animal Models in Neurological Disorders;2023